Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the issue, conversion or payment up of unquoted equity securities, as detailed in their latest Appendix 3G filing with the ASX. These securities are part of a transaction previously announced on 24 July 2024 and are not intended to be quoted on the ASX. The company confirms that no further issues of securities are expected to complete the transaction.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
